2016
DOI: 10.1007/s00702-016-1603-9
|View full text |Cite
|
Sign up to set email alerts
|

Therapies for Parkinson’s diseases: alternatives to current pharmacological interventions

Abstract: Parkinson's disease (PD) is the second most common neurodegenerative disorder caused by the selective and progressive loss of dopaminergic neurons in the substantia nigra pars compacta. Although PD has been heavily researched, the precise etiology and pathogenesis for PD are still inconclusive. Consequently, current pharmacological treatments for PD are largely symptomatic rather than preventive and there is still no cure for this disease nowadays. Moreover, nonmotor symptoms caused by intrinsic PD pathology o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
28
0
1

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 44 publications
(29 citation statements)
references
References 214 publications
0
28
0
1
Order By: Relevance
“…Non-motor symptoms like sleep problems, depression and loss of smell have recently gained an increased attention and were included among the diagnostic criteria [21]. Although PD has been extensively researched since its discovery by James Parkinson in 1817, the exact etiology and pathogenesis that underlie dopaminergic cell death are still unclear [11]. However, numerous epidemiological studies revealed that there is a strong association between sporadic PD which represents more than 90% of PD cases and environmental factors such as environmental toxins, pesticides and heavy metals [9].…”
Section: Introductionmentioning
confidence: 99%
“…Non-motor symptoms like sleep problems, depression and loss of smell have recently gained an increased attention and were included among the diagnostic criteria [21]. Although PD has been extensively researched since its discovery by James Parkinson in 1817, the exact etiology and pathogenesis that underlie dopaminergic cell death are still unclear [11]. However, numerous epidemiological studies revealed that there is a strong association between sporadic PD which represents more than 90% of PD cases and environmental factors such as environmental toxins, pesticides and heavy metals [9].…”
Section: Introductionmentioning
confidence: 99%
“…Current pharmacological treatments for PD are symptomatic and associated with various side effects. Accumulating evidence has revealed the anti‐ageing and neuroprotective effects of natural products from traditional medicines, which may provide alternative therapies for neurodegenerative disorders including PD (Shen et al , ; Kim et al , ; Li et al , ; Islam et al , ; Solanki et al , ; Sun et al , ). Because targeting ALP has recently proposed as a promising strategy for PD and other neurodegenerative diseases (Menzies et al , ), the protective effects of genetically or pharmacologically activated ALP have been tested in experimental models of PD in recent years.…”
Section: Resultsmentioning
confidence: 99%
“…Leading to movement control impairment, motor symptoms are considered cardinal in PD. Consequently, they are the primary focus (Li, Dong, Cheng, & Le, 2016;Glickman-Simon, Karp, & Sethi, 2015;Yang, Qiu, Hao, Lv, Jiao, & Teng, 2015;Yang, Hao, Tian, Gong, Zhang, Shi, Zhao, 2015).…”
Section: Resultsmentioning
confidence: 99%